• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆对比磁共振成像背景实质增强从早期与延迟后对比序列定量:与乳腺癌存在的相关性。

DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence.

机构信息

Departments of Radiology, Biomedical Informatics, and Bioengineering, University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA, 15260, USA.

Magee-Womens Hospital of University of Pittsburgh Medical Center, 300 Halket St, Pittsburgh, PA, 15213, USA.

出版信息

Sci Rep. 2017 May 18;7(1):2115. doi: 10.1038/s41598-017-02341-8.

DOI:10.1038/s41598-017-02341-8
PMID:28522877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5437095/
Abstract

We investigated automated quantitative measures of background parenchymal enhancement (BPE) derived from an early versus delayed post-contrast sequence in breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for association with breast cancer presence in a case-control study. DCE-MRIs were retrospectively analyzed for 51 cancer cases and 51 controls with biopsy-proven benign lesions, matched by age and year-of-MRI. BPE was quantified using fully-automated validated computer algorithms, separately from three sequential DCE-MRI post-contrast-subtracted sequences (SUB1, SUB2, and SUB3). The association of BPE computed from the three SUBs and other known factors with breast cancer were assessed in terms of odds ratio (OR) and area under the receiver operating characteristic curve (AUC). The OR of breast cancer for the percentage BPE measure (BPE%) quantified from SUB1 was 3.5 (95% Confidence Interval: 1.3, 9.8; p = 0.015) for 20% increments. Slightly lower and statistically significant ORs were also obtained for BPE quantified from SUB2 and SUB3. There was no significant difference (p > 0.2) in AUC for BPE quantified from the three post-contrast sequences and their combination. Our study showed that quantitative measures of BPE are associated with breast cancer presence and the association was similar across three breast DCE-MRI post-contrast sequences.

摘要

我们在一项病例对照研究中调查了乳腺动态对比增强磁共振成像(DCE-MRI)中早期与延迟对比后序列衍生的背景实质增强(BPE)的自动定量测量值与乳腺癌存在之间的关联。对 51 例癌症病例和 51 例经活检证实为良性病变的对照进行了回顾性 DCE-MRI 分析,这些对照按年龄和 MRI 年份匹配。使用完全自动化的验证计算机算法分别从三个连续的 DCE-MRI 对比后减去序列(SUB1、SUB2 和 SUB3)中定量 BPE。根据比值比(OR)和接受者操作特征曲线(ROC)下面积(AUC)评估从三个 SUB 计算的 BPE 和其他已知因素与乳腺癌的关联。从 SUB1 定量的 BPE%(BPE%)的乳腺癌 OR 为 3.5(95%置信区间:1.3, 9.8;p=0.015),BPE 增加 20%。从 SUB2 和 SUB3 定量的 BPE 也获得了略低但具有统计学意义的 OR。从三个对比后序列及其组合定量的 BPE 的 AUC 没有显著差异(p>0.2)。我们的研究表明,BPE 的定量测量值与乳腺癌的存在有关,并且在三个乳腺 DCE-MRI 对比后序列中,其相关性相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/2a483424a043/41598_2017_2341_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/084a9b085b24/41598_2017_2341_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/6d266ec630b4/41598_2017_2341_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/2a483424a043/41598_2017_2341_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/084a9b085b24/41598_2017_2341_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/6d266ec630b4/41598_2017_2341_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7616/5437095/2a483424a043/41598_2017_2341_Fig3_HTML.jpg

相似文献

1
DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence.钆对比磁共振成像背景实质增强从早期与延迟后对比序列定量:与乳腺癌存在的相关性。
Sci Rep. 2017 May 18;7(1):2115. doi: 10.1038/s41598-017-02341-8.
2
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.正常乳腺实质的乳腺MRI对比增强动力学与乳腺癌的存在相关。
Breast Cancer Res. 2016 Jul 22;18(1):76. doi: 10.1186/s13058-016-0734-0.
3
Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement.超快速 DCE-MRI 鉴别妊娠相关乳腺癌病灶与哺乳期相关背景实质强化。
Eur Radiol. 2023 Nov;33(11):8122-8131. doi: 10.1007/s00330-023-09805-8. Epub 2023 Jun 6.
4
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.乳腺MRI中背景实质强化的定量评估可预测降低风险的输卵管卵巢切除术的反应:BRCA1/2突变携带者队列的初步评估
Breast Cancer Res. 2015 May 19;17:67. doi: 10.1186/s13058-015-0577-0.
5
A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations.一种使用动态对比增强磁共振成像(DCE-MRI)检查来改善乳腺癌诊断的新定量图像分析方法。
Med Phys. 2015 Jan;42(1):103-9. doi: 10.1118/1.4903280.
6
Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.背景实质增强及其对超快速动态对比增强 MRI 中病变检测能力的影响。
Eur J Radiol. 2020 Aug;129:108984. doi: 10.1016/j.ejrad.2020.108984. Epub 2020 Apr 18.
7
The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.背景实质强化在乳腺 MRI 与乳腺癌的相关性:一项系统评价和荟萃分析。
Radiology. 2019 Sep;292(3):552-561. doi: 10.1148/radiol.2019182441. Epub 2019 Jun 25.
8
Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.背景实质强化对磁共振成像检测乳腺癌的影响。
Diagn Interv Imaging. 2016 Mar;97(3):315-20. doi: 10.1016/j.diii.2015.12.006. Epub 2016 Mar 10.
9
Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the DENSE trial.在 DENSE 试验中,不影响与乳腺癌的相关性的情况下,对极度致密乳腺 MRI 中的背景实质强化进行自动评分。
Eur J Radiol. 2024 Jun;175:111442. doi: 10.1016/j.ejrad.2024.111442. Epub 2024 Mar 24.
10
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.鉴定乳腺癌影像学表型与分子亚型之间的关系:模型发现与外部验证。
J Magn Reson Imaging. 2017 Oct;46(4):1017-1027. doi: 10.1002/jmri.25661. Epub 2017 Feb 8.

引用本文的文献

1
The mechanism of electroacupuncture-mediated improvement in Parkinson's disease by inhibiting ferroptosis through activating the Nrf2/GPX4 signal pathway.电针通过激活Nrf2/GPX4信号通路抑制铁死亡介导帕金森病改善的机制。
Front Aging Neurosci. 2025 May 7;17:1551404. doi: 10.3389/fnagi.2025.1551404. eCollection 2025.
2
Rapid lung ventilation MRI using parahydrogen-induced polarization of propane gas.利用丙烷气体的仲氢诱导极化进行快速肺通气磁共振成像
Analyst. 2024 Dec 2;149(24):5832-5842. doi: 10.1039/d4an01029a.
3
Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.

本文引用的文献

1
Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways.无监督的定量图像表型聚类揭示了具有不同预后和分子途径的乳腺癌亚型。
Clin Cancer Res. 2017 Jul 1;23(13):3334-3342. doi: 10.1158/1078-0432.CCR-16-2415. Epub 2017 Jan 10.
2
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.正常乳腺实质的乳腺MRI对比增强动力学与乳腺癌的存在相关。
Breast Cancer Res. 2016 Jul 22;18(1):76. doi: 10.1186/s13058-016-0734-0.
3
MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
预测乳腺癌患者新辅助化疗的病理完全缓解:使用来自三个区域的 MRI 放射组学数据和多种机器学习算法。
J Cancer Res Clin Oncol. 2024 Mar 21;150(3):147. doi: 10.1007/s00432-024-05680-y.
4
Assessment of Background Parenchymal Enhancement at Dynamic Contrast-enhanced MRI in Predicting Breast Cancer Recurrence Risk.动态对比增强 MRI 背景实质强化评估预测乳腺癌复发风险。
Radiology. 2024 Jan;310(1):e230269. doi: 10.1148/radiol.230269.
5
Generalizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI.用于乳腺动态对比增强磁共振成像中纤维腺组织分割及背景实质强化的通用注意力U型网络
Insights Imaging. 2023 Nov 6;14(1):185. doi: 10.1186/s13244-023-01531-5.
6
Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE Study.基于 MRI 的全自动背景实质增强量化评估与乳腺癌患病风险的相关性:IMAGINE 研究。
Radiology. 2023 Sep;308(3):e230367. doi: 10.1148/radiol.230367.
7
Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities.超越乳腺密度:多种影像学模式下乳腺癌的风险评估指标。
Radiology. 2023 Mar;306(3):e222575. doi: 10.1148/radiol.222575. Epub 2023 Feb 7.
8
Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI.乳腺癌新辅助治疗的反应预测性:动态对比增强磁共振成像中背景实质强化的定性分析
J Pers Med. 2021 Apr 1;11(4):256. doi: 10.3390/jpm11040256.
9
Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score.背景:乳腺MRI实质强化作为一种预后替代指标:与乳腺癌Oncotype Dx评分的相关性
Front Oncol. 2021 Feb 4;10:595820. doi: 10.3389/fonc.2020.595820. eCollection 2020.
10
Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis.乳腺癌与乳腺磁共振成像背景实质强化:一项荟萃分析。
BMC Med Imaging. 2021 Feb 19;21(1):32. doi: 10.1186/s12880-021-00566-8.
MRI背景实质强化与乳腺癌无关。
PLoS One. 2016 Jul 5;11(7):e0158573. doi: 10.1371/journal.pone.0158573. eCollection 2016.
4
Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions.简化联合磁共振成像方案:一种用于乳腺病变特征描述的新的更快策略。
Clin Breast Cancer. 2016 Jun;16(3):207-11. doi: 10.1016/j.clbc.2016.02.008. Epub 2016 Feb 11.
5
Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.乳腺磁共振成像背景实质强化(BPE)与乳腺癌风险相关。
Magn Reson Imaging. 2016 Feb;34(2):173-6. doi: 10.1016/j.mri.2015.10.014. Epub 2015 Oct 24.
6
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.乳腺MRI中背景实质强化的定量评估可预测降低风险的输卵管卵巢切除术的反应:BRCA1/2突变携带者队列的初步评估
Breast Cancer Res. 2015 May 19;17:67. doi: 10.1186/s13058-015-0577-0.
7
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
8
Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.第五版 BI-RADS MRI 词汇表在乳腺成像中的观察者间变异性。
AJR Am J Roentgenol. 2015 May;204(5):1120-4. doi: 10.2214/AJR.14.13047.
9
Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection?乳腺MRI的简化方案:癌症检测需要多个序列吗?
Eur J Radiol. 2015 Jan;84(1):65-70. doi: 10.1016/j.ejrad.2014.10.004. Epub 2014 Oct 16.
10
Rethinking breast cancer screening: ultra FAST breast magnetic resonance imaging.重新思考乳腺癌筛查:超快乳腺磁共振成像
J Clin Oncol. 2014 Aug 1;32(22):2281-3. doi: 10.1200/JCO.2014.56.1514. Epub 2014 Jun 23.